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1Department of Chemical and Environmental Engineering, University of California, Riverside, CaliforniaABSTRACT Hepatitis B virus (HBV) controls genome encapsidation and reverse transcription from a single-stranded RNA to a
double-stranded DNA through the flexible C-terminal domain (CTD) of the capsid proteins. Although the microscopic structure of
the nucleocapsid plays a critical role in the life cycle of HBV, the location of CTD residues at different stages of viral replication
remains poorly understood. In this work, we report the radial distributions of individual amino-acid residues of the CTD tails
for both empty and RNA-containing HBV capsids by using a coarse-grained model for the key biological components and the
classical density functional theory. The density functional theory calculations reveal substantial exposure of the CTD residues
outside the capsid, in particular when it is devoid of any nucleic materials. The outermost layer of the capsid surface mainly
consists of residues from 170Ser-175Arg of the CTD tails, i.e., the serine-arginine protein kinase binding motif. The theoretical
description corroborates recent in vitro studies that show a transient CTD distribution captured by serine-arginine protein kinase
binding. We have also investigated the nucleocapsid structural changes due to phosphorylation of serine residues and shown a
correlation between the CTD location and the internal distribution of RNA segments.INTRODUCTIONHepatitis B virus (HBV) is a human pathogen infecting
around 2 billion people worldwide. Acute and chronic
HBV infection may cause serious dysfunctions including
liver fibrosis, cirrhosis, and cancer (1). The HBV virion,
also known as Dane particle, has a double-shelled structure
consisting of surface proteins and nucleocapsid (NC) con-
taining a circular partially double-stranded DNA (dsDNA).
The HBV capsid is formed by the self-assembly of the
capsid proteins with a pregenomic RNA (pgRNA) and the
viral polymerase (Pol), a reverse transcriptase for transfor-
mation of pgRNA to dsDNA (2–4). Each NC has an icosa-
hedral structure with triangulation number T ¼ 3 or 4. T4 is
the major form (95%) in vivo, which is made of 240 copies
of the core protein (CP) (5–7). Awild-type (WT) CP has 183
amino-acid (aa) residues, including an assembly domain (1–
140 aa), a nonapeptide linker (141–149 aa), and the C-termi-
nal domain (CTD, 150–183 aa). The assembly domain has a
rigid structure that contributes to the capsid scaffold. How-
ever, both the linker and the CTD chains are flexible; the
latter is referred to as protamine tails because they are
rich in arginine residues (8,9).
It has been long recognized that CTD plays an essential
role in the life cycle of HBV infection (8). The HBV capsid
is fenestrated with symmetrical pores that allow mass trans-
port and the extrusion of the CTD tails (10–12). The expo-
sure of the CTD tails affects genome packaging, nuclear
entry, as well as capsid envelopment and egress (8,13,14).Submitted May 20, 2014, and accepted for publication July 15, 2014.
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0006-3495/14/09/1453/9 $2.00In addition, it has been recognized that the CTD tails are
involved in signaling capsid maturation (15–17). Because
CTD exposure alters the surface properties of the NC parti-
cle, its location at different stages of replication is critical to
differentiate the mature and immature NCs. If the CTD
chains were truncated by mutation, the CPs would be unable
to encapsidate the full content of the pgRNA, generating
capsids with a smaller amount of DNA or empty capsids
(8). In addition, each CTD chain has three phosphorylation
sites (S155, S162, and S170) important for RNA encapsida-
tion and reverse transcription (8,13). For the WT virus, the
CTD chains are phosphorylated at the early stage of repli-
cation (with pgRNA or intermediate DNA) (14), but depho-
sphorylated for matured capsids (with dsDNA) (18,19).
Replacing three serine residues with charged amino acids
affects pgRNA encapsidation and DNA synthesis. For
example, a phosphorylated analog, with one serine residue
replaced by glutamic acid, is able to package the pgRNA
but fails to support viral DNA replication (13). Meanwhile,
substantial reduction of RNA packaging was observed by
substitution of serine with aspartic acid (20,21). The CTD
chains are also important in viral replication because only
phosphorylated capsids were allowed to transport into
cellular nucleus (22). Despite such significance, the kinase
responsible for the CTD phosphorylation remains little
known. Because all phosphorylated serine residues at
CTD are followed by repeated arginine residues, serine/argi-
nine protein kinase (SRPK) was suggested as one of the can-
didates (23,24). It has been demonstrated experimentally
that SRPK is effective to phosphorylate capsid proteins
in vitro (25).http://dx.doi.org/10.1016/j.bpj.2014.07.032
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as well as intracellular trafficking of HBV capsids (16,22),
it is imperative to determine the spatial distribution during
different stages of replication. Regrettably, experimental
detection of the CTD structure has been elusive. Whereas
the assembly domain of HBV capsids maintains a relatively
rigid structure, CTD chains are highly flexible and their
structure is changing in response to the evolving genome
(15,22,26–29). Recently, the enzymatic recognition of
SRPK was used to analyze the location of CTD tails
(30). The in vitro experiments for the binding affinity of
SRPK with HBV capsids indicate that the CTD tails are
exposed at the surface when the capsid does not contain
any nucleic materials. Conversely, the CTD tails are mainly
distributed inside the capsid for the RNA-containing nucle-
ocapsids (30). Regrettably, the CTD chains were not visible
through a conventional microscopy such as cryo-electron
microscopy (cryo-EM) (7,31). Only a few recent studies
capture a trace amount of CTD chains through recon-
structed EM images (29,32). Besides, HBV capsids ex-
pressed in Escherichia coli contain the bacterial RNA
instead of pgRNA (22,25,29,30,33). The in vitro assembly
of HBV capsids typically occurs at an electrolyte con-
centration much larger than that corresponding to the
physiological condition. The high salinity is required not
only to avoid capsid aggregation but also to maintain the
thermodynamic stability of the reassembled capsids (25).
Although DNA-containing viral particles are available
from expression in mammalian cells at physiological con-
ditions, a discrete separation of the capsids at each matura-
tion state is currently impracticable. Detection of the capsid
structure is also complicated by the intracellular environ-
mental effects (34).
Previously, we developed a theoretical platform for pre-
dicting the microscopic structure and thermodynamic
properties of HBV nucleocapsids using a coarse-grained
(CG) model for the key viral components and the classi-
cal density functional theory (DFT) (35,36). Our model
predicted a quantitative relationship between the CTD
length and the genome content in good agreement with
experimental data. In this work, we apply the same model
to locate the SRPK binding motif by analyzing its affinity
with HBV capsids at different distributions of the
CTD tails. Specifically, we consider CTD distributions
in HBV capsids either with or without RNA as examined
in recent experiments (29). In addition, we study the
structural reorganization of RNA chains due to CTD
phosphorylation.MOLECULAR MODEL AND METHODS
As in our previous work (35,36), we use a CG model to ac-
count for nonspecific interactions among the key ingredients
of the HBV capsid, i.e., RNA and CTD chains in an electro-
lyte background. Whereas the atomistic details, includingBiophysical Journal 107(6) 1453–1461the secondary structure of RNA, are unquestionably impor-
tant to the biological functions and the kinetics of encapsi-
dation, the essential features of the genome packaging and
its interaction with the flexible domains of the capsid pro-
teins are mainly affiliated with electrostatic interactions
and molecular excluded volume effects. The nature of
nonspecific interactions can be justified by the fact that
HBV capsids expressed in E. coli have RNA content similar
to that in the WT capsids (12).
In our theoretical calculations, the electrostatic interac-
tions and molecular excluded-volume effects are described
with tangentially connected chains of hard spheres that
each corresponds to one amino-acid residue or nucleotide.
We assume that all RNA segments have the same diam-
eter, sR ¼ 0:75 nm, and electrostatic valence of ZR ¼ 1
(37). The diameter of CTD segments, sT ¼ 0:5 nm, re-
flects the average van der Waals diameter of amino-acid
residues (38). The electrical charge corresponds to the
characteristic value of each amino-acid residue under
physiological condition, and is assigned with the valence
of þ1, 0, and 1. Specifically, Z ¼ þ1 is assigned to argi-
nine, 1 for glutamate, and all other residues carry no net
charge.
The primitive model of electrolyte solutions is used to
describe salt ions and water molecules in the background.
As in the experimental work (29), the surrounding environ-
ment for the HBV capsids is represented by a NaCl solution
at concentration of 0.14 M. Approximately, Naþ and Cl
have the diameters of sNa ¼ 0:39 nm and sCl ¼ 0:36 nm,
respectively, and the dielectric constant for water is 78.4
(39). The pair potential between ions includes a hard-sphere
repulsion and a Coulomb energy:
buijðrÞ ¼
8<
:
N; r<sij
zizjlB
r
; rRsij
; (1)
where b ¼ 1=kBT, kB is the Boltzmann constant, T ¼ 298
K, sij ¼ ðsi þ sjÞ=2, and lB ¼ 0:714 nm is the Bjerrum
length. Equation 1 is also applied to the pair interaction
between the polymeric segments. The bonding potential
between the CG RNA segments is described by the Dirac
d-function:
exp½  bVRNAðRÞ ¼
YM1
i¼ 1
dðjriþ1  rrj  sRÞ
4ps2R
; (2)
where M is the degree of polymerization, and
R ¼ ðr1; r2;/rMÞ specifies the positions of monomeric seg-
ments. The CTD tails (and 9 aa linkers) are also modeled as
tangentially connected spheres of the same size but different
valences.
As mentioned previously, the HBV capsids are fenes-
trated with pores ~1.5 nm in diameter, allowing the perme-
ation of salt ions and CTD tails but not the RNA genome
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Rin ¼ 13 nm and Rout ¼ 15 nm, respectively (41). The
confinement effect for the RNA segments can be described
as a spherical cavity with a hard-wall potential
fRNAðrÞ ¼
8<
:
N; r>Rin  sR
2
0; otherwise
: (3)
The linker-CTD tails are partially confined with the first
linker segment tethered at the inner surface of the capsid.
Whereas certain capsid pores are more favorable for tail
permeation (11,33,40), we estimate the overall probability
(10%) considering the approximated ratio of total pore
area to inner capsid area. Accordingly, we set an external
potential for the tail segments,
bfTailðrÞ ¼

lnð0:1Þ; Rin  0:5 sT<r<Rout þ 0:5 sT
0; otherwise
:
(4)
We assume the charges on the capsid are uniformly
distributed over a spherical surface located at r ¼ 15 nm.
The small ions are distributed either inside or outside the
HBV capsid. According to previous investigations (42,43),
the charge density of the capsid is Qc ¼ 0:7 e = nm2, where
e denotes the unit charge. The linker-CTD tails are tethered
on the inner capsid surface.
Application of the DFT to electrolyte solutions and poly-
mers has been well documented (44–47). In our previous
work (35,39), we showed that the DFT performs well for
the electrostatic interactions and the excluded volume ef-
fects. The Supporting Material details the equations used
in the DFT calculations.FIGURE 1 Schematic representations of empty and RNA-conRESULTS
Empty capsid versus RNA-containing NC
We consider first the radial distributions of the polymeric
segments and small ions for empty and RNA-containing
capsids. Fig. 1 shows the schematic structure of empty
capsid and nucleocapsid. In DFT calculations, the HBV
capsid is depicted as a spherical shell (the dashed lines) of
2 nm in thickness, corresponding to the average diameter
of a capsid dimmer. The CG RNA, CTD of capsid proteins
are shown as tangentially connected spheres, and the salt
ions are shown as black and red dots. Accordingly to exper-
iments, the CTD tails are primarily exposed outside the
empty capsid, whereas the formation of RNA-NC complex
severely restricts their exposure.
The DFT calculations provide the density profiles of
polymeric segments and small ions. Fig. 2 shows that, in
the absence RNA, the CTD chains distribute like that of a
typical polymer brush on both sides of the capsid. The oscil-
latory density profile within the protein shell reflects the mo-
lecular excluded volume effects amplified by an artificial
wall potential. The distributions of small ions outside the
capsid surface constitute an electric double layer (EDL),
i.e., a strong accumulation of counterions accompanied by
depletion of coions. Different from a typical EDL, however,
the counterions are not directly in contact with the surface
charge. Instead, counterion accumulation arises mainly
from the CTD brush distributed inside the capsid. Within
the CTD brush, the counterion density is significantly lower
than the density of polymer segments. As a result, it swells
significantly more in comparison with a normal polyelectro-
lyte brush (48). The concentrations of cations and anions are
nearly identical at the capsid center, where the salt concen-
tration is virtually the same as that in the bulk solution.taining HBV capsids. To see this figure in color, go online.
Biophysical Journal 107(6) 1453–1461
FIGURE 2 The radial distributions of polymeric segments in empty and
RNA-containing HBV capsids. The density profiles of salt ions, segments
of linker-CTDs, and RNA chains are shown for the empty capsid (A) and
the nucleocapsid (B). In this and other figures, the perpendicular dotted
lines indicate the inner and outer positions of the capsid surface. To see
this figure in color, go online.
1456 Kim and WuBecause the CTD chains are tethered near the capsid pores,
they do not contribute to the Donnan equilibrium. As a
result, there is no uneven distribution of free ions far from
the capsid shell.
Fig. 2 b shows the radial distributions of polymeric seg-
ments and small ions within the RNA-containing capsid.
Interestingly, encapsidation of the RNA chain does not
lead to significant changes in the density profiles of cations
and anions within the EDL at the capsid out surface. How-
ever, the CTD brush outside the NC virtually disappears,
indicating that the CTD tails are mostly confined within
the NC due to the strong electrostatic attraction between
RNA and CTD chains. The microscopic structure of the
NC inside is also quite different from that of the empty
capsid. First of all, the counterions within the CTD brush
are virtually replaced by the RNA segments. Indeed, theBiophysical Journal 107(6) 1453–1461counterions are almost depleted as one may expect from
the Donnan equilibrium. Because the CTD chains are
mostly confined with the capsid, the brush in NC is slightly
thicker than that in the empty capsid. Because the CTD
chains are rather extended within the NC, the RNA seg-
ments distribute almost uniformly within the brush. Such
structure inside the NC cannot be detected with conven-
tional cryo-EM methods but probably measureable with
neutron or x-ray scattering.The location of CTD residues
A recent in vitro study of HBV structure by Chen et al. (30)
indicates that the CTD chains are exposed outside the capsid
shell for empty capsids, whereas they are confined inside
the capsid for RNA-containing NCs. By analyzing CTD in-
teraction with the surrounding molecules in the solution,
Chen et al. provided additional information for the specific
sequence of exposed CTD segments. Motivated by these
in vitro results for the HBV structure, we have examined the
density profiles for the individual segments of the CTD tails.
The DFT allows us to determine the distributions of indi-
vidual residues of the CTDs. The distribution data may be
analyzed in several ways. Here, we first consider the accu-
mulated number of linker-CTD residues as a function of
the radial distance r from the capsid center. The sum of
all residues at each radial distance is normalized by the total
number of amino acid residues, namely, 240. Except for the
first tail segment, 42 of the linker-CTD segments are traced,
thus the accumulated number of CTD residues changes from
0 to 42 as r increases. For the empty capsid (Fig. 3 a), the
accumulated number of CTD residues is ~29 at the inner
capsid wall (r ¼13 nm) and 30 at the outer surface (r ¼
15 nm). Accordingly, 30 residues are on average located in-
side the empty capsid, and 12 residues are exposed outside.
However, for RNA-containing NC (Fig. 3 b), the accumu-
lated number of linker-CTD residues is ~40 at the outer sur-
face (r ¼ 15 nm), indicating that only 2 CTD residues are
distributed outside the capsid (r > 15 nm). At r ~ 19 nm
from the center of the NC, the accumulated number of
linker-CTD residues approaches 42. For the empty capsid
(Fig. 3 a), CTD residues are distributed further from the
capsid center (up to r ¼ 22 nm). These theoretical results
suggest how the surface characters are different between
the empty and NC due to the extruded CTD residues. We
have also considered the distribution data in terms of
charged or neutral amino acid groups but find not much vari-
ation between the empty and RNA-containing capsids.
Fig. 4 compares the exposed ratio of individual CTD seg-
ments. A segment is 100% of exposure if it is fully distrib-
uted in the outer region of the capsid, i.e., r R 17 nm. We
assume that the residues in the outer region are able to fully
interact with surrounding molecules like cellular enzymes.
For convenience, we rank each residue according to its po-
sition at the CTD chain, i.e., 1 represents the amino acid
FIGURE 3 The accumulated number of CTD residues for the empty (a)
and RNA-containing (b) HBV capsids. The accumulated number is ob-
tained from a radial integration of the density profiles shown in Fig. 2 for
the linker-CTD residues and normalized by the number of overall CTD tails
(Nt¼ 240). In other words, the y axis corresponds to the summed number of
residues per CTD tail up to the radial distance (r) from the capsid center.
As r increases, the summed value approaches 42, which is the total number
of traced residues for each tail. The accumulated values for charged
(þ and ), neutral ($) residue groups are shown separately. To see this
figure in color, go online.
FIGURE 4 The ratio of the exposed CTD residues exposed to the outer
region of HBV capsids. The CTD residues exposed in the region
rR17 nm are counted for both the empty capsid and nucleocapsid. Each
residue is ranked from the tethering site (1) to the end segment (34), and
the panel above denotes amino-acid residues. To see this figure in color,
go online.
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residue. As expected, the empty capsid shows higher overall
CTD exposure compared to the NC. Assuming that the RNA
content is mainly responsible for the deviation between the
empty capsid and the NC, we find that the attraction be-
tween CTDs and RNA internalizes more than half of the
exposed CTD segments in the empty capsid. In the latter
case, the exposed ratio peaks around the 21–26th residues
(170Ser-171Pro-172Arg-173Arg-174Arg-175Arg), which over-
lap with a typical binding motif of SRPK (49,50).
Schematically, Fig. 5 depicts the distribution of CTD res-
idues for the empty capsid according to our DFT calcula-tions. Because the end residues have a lower exposure rate
than the 21–26th residues, a CTD tail must somehow bend
in the middle, making it have a hook-like shape. The bent
structure increases the possibility of the motif to contact
with the SRPK. According to our DFT predictions, ~30%
present of the residues in such motif are within the reach
of the SRPK kinase.
The in vitro study by Chen et al. (30) indicated the tran-
sient CTD location in HBV capsids. It revealed the associ-
ation of SRPK on the outer surface of the empty capsid,
mediated by the enzyme-binding motif in the CTD. The
same assay was conducted for the NC containing RNA
genome but in that case, the enzyme binding was mostly in-
hibited. The SRPK binding demonstrated unequivocally that
the surface characteristics of the capsid changed with the
CTD location. Corresponding to the experimental approach,
the DFT results capture the transient feature of the capsid
surface, rendering additional evidence on the interaction
of CTD with SRPK.The effect of phosphorylation
The CTD distribution is sensitive to the phosphorylation of
serine (S) residues (29). In WT capsids, three of the serine
residues (S155, S162, S170) have been recognized as phos-
phorylated upon the capsid formation and packaging with
pgRNA (8,13). In our DFT calculations, phosphorylation
can be studied simply by setting the valence of those three
serine residues from 0 to 1 for the phosphorylated case.Biophysical Journal 107(6) 1453–1461
FIGURE 5 Schematic representation of the
CTD location. (A) Twofold capsid pore and a
dimer of the capsid CP. (B) 6 CTD tails in each
twofold pore. (C) CTD tails of the empty capsid.
Here, the tails are distributed both inside and
outside the empty capsid through the twofold
hole. Red segments indicate the SRPK-binding
motif. To see this figure in color, go online.
1458 Kim and WuThe addition of negative charges affects both the RNA dis-
tribution and the exposure of CTD chains.
Fig. 6 shows that the RNA structure inside the capsid
varies significantly in response to CTD phosphorylation.
Compared to the unphosphorylated case, the RNA segments
become more uniformly distributed and are positioned
closer to the capsid surface. CTD phosphorylation makes
the RNA distribution transduced to have a relatively higher
peak near the capsid surface. Phosphorylation reduces the
extend CTD exposure outside the capsid. Because the addi-
tion of negative charge reduces intrachain electrostatic
repulsion, the CTD brush is slightly collapsed in comparison
to the unphosphorylated brush.DISCUSSION
Implication of the CTD exposure
Several recent investigations presented the transient expo-
sure of CTDs to the capsid surface (16,22,27,41,51,52). It
has been postulated that the exposed CTDs regulate the
posttranslational process of HBV core, i.e., the trafficking
into nucleus and the enveloped secretion. Kann et al. (53)
determined the fraction of the exposed CTDs for NC in
different maturation stages, and suggested the CTD-asso-
ciated signal modulates the capsid delivery into cellular
nucleus. Ning et al. (34) observed that the secreted HBV
particles contained either empty capsids or NC with dou-
ble-stranded DNA, whereas the immature NCs, i.e., those
filled with pgRNA or single-stranded DNA, were excluded
from secretion. Accordingly, a hypothesis was set such
that the immature NCs negatively regulate the trafficking
process (29,30,34). Zlotnick’s group compared the struc-
tural characteristics of empty and RNA-NC, and suggestedBiophysical Journal 107(6) 1453–1461that the strong interaction of CTDs with RNA genome ob-
structs the CTD exposure.
Our theoretical model supports the mechanism of
genome-regulated exposure of CTDs. Although we are
not describing the whole process of HBV replication, a
substantial structural change of CTD implies its functional
correlation with the maturation signaling. Our model pre-
dicts that about 10 residues for each CTD tail (34 residues)
are exposed outside the capsid when the tails are free from
the genome contents. Thus, ~30% of CTD segments addi-
tionally extruding outside would modify the capsid sur-
face characteristics, which trigger the cellular trafficking.
For empty capsids, the CTD tails have been suggested
to extrude into far space from the capsid center, so that
the outermost reachable r is ~19 nm for RNA-NC but
~22 nm for the empty capsid. Such a structural deviation
between empty and RNA-filled capsid supports the hypoth-
esis that the degree of CTD exposure may trigger selective
selection upon the posttranslational process (29,30,34). The
hypothesis, specifically, the rationale on the transient CTD
structure, was also endorsed by experiments (29,30). In
supporting those observations, our model gives evidence
on the CTD exposure and accessibility into outer capsid
space.Structural changes associated with CTD
phosphorylation
It was postulated that HBV carries serine residues in
different phosphorylation states during the process of the
capsid assembly and reverse transcription of the genome.
Specifically, in a duck hepatitis B virus, the capsid proteins
(CP) were in phosphorylated form upon the capsid assem-
bly. However, they were dephosphorylated for the mature
FIGURE 6 Effect of phosphorylation on the distributions of RNA
and linker-CTD tails. (A) RNA distribution in phosphorylated (pCTD)
and unphosphorylated (CTD) capsids. (B) The distributions of phosphory-
lated (pCTD) and unphosphorylated CTD tails. To see this figure in color,
go online.
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the phosphorylation state is believed to control the pgRNA
encapsidation as well as the reverse transcription. Mutation
of phosphorylation sites on CTD to mimic unphosphoryla-
tion hindered RNA packaging (20,21,55). Similar mutation
studies showed CTD phosphorylation affects DNA synthe-
sis (14,21,55). We have investigated the structural effect
of phosphorylation. The DFT calculation shows that CTD
phosphorylation induces RNA segments to be more local-
ized toward the inner capsid surface (Fig. 6). Such a RNA
structure alteration was observed by Wang et al. (29). In
the phosphorylation-mimic case, the pgRNA inside the
capsid shows more ordered structure than that in E. coli-
derived nucleocapsid. Our theoretical analysis indicates
that such a structural ordering of RNA is correlated with
the CTD location. In the phosphorylated state, more of the
CTDs are localized at the region between 7 and ~12 nmfrom capsid center, and the inner shell (<7 nm) distribution
of the phosphorylated CTDs is relatively depleted. It is ex-
pected that the RNA-CTD interaction would be reduced
because of added negative charges to the CTD by the phos-
phorylation. Fig. 6 shows such retarded complex formation
between RNA and CTDs. At the inside region (r < 7 nm),
density profile of RNA for the phosphorylated case is higher
than that for the unphosphorylated one. However, cor-
responding densities of CTD segments for each case are in-
versed at the region, thus the unphosphorylated CTD chains
show higher segmental density than phosphorylated CTD
chains. In other words, CTD chains stay relatively apart
from the RNA when they gain additional negative charges
by the phosphorylation. Accordingly, phosphorylation re-
sults in higher RNA density close to the inner surface of
the capsid, and it maintains monotonic radial distribution
except near the inner wall. By contrast, RNA in the unphos-
phorylated case shows more inhomogeneous distribution.Exposure of SRPK-binding motif in the CTD
Although the primary kinase responsible for HBV phos-
phorylation is still under active investigation, SRPK has
been a well-speculated candidate (24,56). SRPK is able to
fulfill the in vitro phosphorylation of HBV CPs (24). More-
over, the binding of this enzyme to every twofold pores of
HBV empty capsid has been reported (30).
Our DFT calculation provides the density distributions of
individual CTD segments in HBV capsids. We find that a
specific motif, 21–26th CTD residues of the CTD, is located
in the outer region ðrR17 nmÞ with the highest probability.
Such a serine/arginine repeats domain serves as an ideal
substrate for SRPK binding and nuclear localization signals
(57,58). At the physiological condition ðCs ¼ 0:14 MÞ; the
exposure fraction of SRPK-binding motif is expected to be
~30% of that corresponding to the empty capsid. A recent
in vitro HBV study showed the empty capsid was decorated
by SRPKs at all of the twofold capsid pores. However,
RNA-NC failed in that binding assay, indicating that
CTDs were not substantially exposed to be accessible for
outside SRPKs (30). Regarding the exposure of kinase
binding motif, the deviation between the empty capsid
and the NC has been confirmed by our DFT calculation.
In the presence of the RNA, the exposed fraction of
SRPK-binding motif of 21–26th CTD segments is reduced
to ~5%.
Chen et al. (30) claimed that no interaction between
RNA-NCs and SRPKs were observed in conducting a chro-
matography of a capsids sample into the SRPK bound col-
umn. However, our theoretical model predicts that CTD
chains are also partially exposed in RNA-containing NCs
but in a relatively much smaller portion. One explanation
for this discrepancy is that the enzyme binding requires suf-
ficient substrate contact as for the case of the empty capsids.
For RNA-containing NCs, the target motif exposure isBiophysical Journal 107(6) 1453–1461
1460 Kim and Wuinsufficient to retain capsids bound on the column. Also in
experiment, the RNA-NCs were obtained from the E. coli
system, filled with the host RNA. Although the bacterial
RNA contents have been regarded to mimic the authentic
pgRNA regarding its amount (7), their characteristics can
be different (59). Accordingly, we assume that the trapped
bacterial RNA induces relatively stronger interaction with
CTDs than pgRNA. The calculation shows that if the size
of RNA in the NC model is set to have larger value than
that of the authentic pgRNA (3.5 kb), the CTD exposure ra-
tio decreases (data not shown). It was observed by Rabe
et al. (15) that the structure of E. coli-derived capsids and
authentic immature capsids were clearly different. In their
analysis, RNA-NCs were obtained in vivo with inhibiting
the reverse-transcription to maintain the pgRNA. A certain
portion of CTDs was exposed outside the capsid, therefore
cleaved by outside digesting enzyme. However, NCs ob-
tained by expressing the capsid protein in E. coli were not
affected by outside enzyme, suggesting their CTDs were
not exposed.
Even for E. coli-derived nucleocapsid with RNA, it was
speculated that a certain portion of CTDs are exposed. Van-
landschoot el al. (60) observed the CTD-mediated attach-
ment of nucleocapsids to glycosaminoglycans expressed
on the plasma membranes of cells. A recent structural anal-
ysis showed that a small portion of CTDs were stretched
out through NC pores (32). These results lead to hypothe-
size that RNA-filled NCs also carry the exposed CTDs
but its fraction is substantially small compared to the empty
capsid. DFT calculation supports that hypothesis with
quantified comparisons. The distinct structures of capsids
suggest that the CTD location, specifically, the distribution
of the kinase target motifs can be modulated in response to
the inside genome. Thus, the phosphorylation process
should be entangled with the genome contents by the
CTD involvement.CONCLUSIONS
To summarize, we proposed a CG model to describe the
radial distributions of the flexible domains of HBV capsids
and encapsidated RNA segments. The molecular model
captures the molecular excluded volume effects and elec-
trostatic interactions among the key viral components.
The predicted density profiles for the C-terminal domains
of the capsid protein (CTD) agree well with experiments,
supporting the hypothesis of CTD exposure outside the
RNA-free HBV capsids. The DFT predictions validate
the important role of CTD location in signaling viral matu-
ration. Furthermore, the theoretical model predicts the
most probable position of a SRPK-binding motif in the
CTD in good agreement with recent experiment. In addi-
tion, we provided a theoretical description for the reorga-
nization of RNA and CTD distributions in response to
phosphorylation.Biophysical Journal 107(6) 1453–1461SUPPORTING MATERIAL
Fourteen equations and supplementary information are available at http://
www.biophysj.org/biophysj/supplemental/S0006-3495(14)00751-6.
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